PALO ALTO, CALIF. AND CAMBRIDGE, MASS. – May 3, 2012 – While clinical development technologies have come a long way in recent years, research sponsors continue to struggle to connect disparate systems and attain easy access to critical data that will enable better reporting, faster problem solving and increased operational efficiencies. In response, Quanticate, the leading data-focused global clinical research organization (CRO), chose Comprehend Clinical™ to integrate into its future research tools as a key part of its strategy to expand its offerings to meet growing sponsor demand for real-time communications and comprehensive clinical data analytics.

Tweet This: #CRO @Quanticate selects @Comprehend for analytics and visualization for #clinicaltrials

“We are excited to be able to provide our sponsor customers a more user-friendly, cost effective approach that overcomes the limitations of analytics and visualization tools that are costly and cumbersome to implement and integrate with other systems. Our approach will help our customers get to the data they need to answer critical questions,” said Daniel Chapple, chief commercial officer at Quanticate. “Our selection of Comprehend Systems is a fundamental step in our vision to provide our customers with centralized clinical data services that helps them resolve this data access challenge.”

After Quanticate conducted a thorough evaluation of a range of data analytics vendors, Comprehend Clinical was chosen for its easy-to-use web-based platform and ability to seamlessly integrate into existing clinical systems. The Quanticate team also valued how the system allows researchers to easily find answers to their problems and dig into key data with no additional programming or complicated spreadsheets.

“During our evaluation process of visualization and analytics software, it became clear that Comprehend Clinical’s competitive advantage is its ability to pull data from any source and deliver it in a way that makes sense to researchers,” said Michael Whitworth, vice president of centralized clinical data sciences at Quanticate. “Comprehend Clinical will enable our sponsors to not only drill down and solve unique, specific problems in real time, but also provide a higher level view of data to tackle broader operational challenges.”

“As a leading CRO, Quanticate clearly understands the regulatory, clinical and financial pressures sponsors are under and is aggressively implementing the technologies and services that solve the industry’s biggest pain points,” said Rick Morrison, CEO and founder of Comprehend Systems. “Given our shared commitment to improving the way clinical research is conducted, Quanticate’s strategy to integrate our solution makes perfect sense, and we look forward to successes with joint customers in the months ahead.”

About Quanticate

Quanticate (www.quanticate.com), with headquarters in the UK and USA, is a specialist clinical research organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. With a global footprint, Quanticate provides efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain functions in their entirety. Clinical trial management services include scalable on-site and off-site data management, statistical consultancy, statistical programming & analysis, medical writing and pharmacovigilance.

About Comprehend Systems, Inc.

Comprehend Systems, Inc. (www.comprehend.com) offers clinical data visualization, analytics and reporting software that improves the way clinical researchers access, understand, explore and analyze data. Designed specifically for clinical researchers, Comprehend Clinical ™ enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Comprehend Systems was founded in 2010 in Palo Alto by a team of entrepreneurs with decades of combined experience in clinical research and software development.

PALO ALTO, CALIF. – April 17, 2011 – Designed to help clinical researchers overcome the ongoing challenge of accessing clean, real-time data and reports, Comprehend Clinical 1.1 from Comprehend Systems includes a range of new features that enable sponsors to meet increasing regulatory requirements and leverage industry standards to easily share data across all systems in the clinical trials process.

“From sponsors and CROs to EDC and CTMS companies, everyone is looking for ways to understand how to reduce costs and increase efficiencies, but are still hitting expensive and time-consuming roadblocks when it come to accessing and sharing the data they need to make critical decisions,” said Rick Morrison, CEO of Comprehend Systems. “With this latest release, Comprehend Clinical continues to ease sponsors’ biggest pain points in accessing data, resolving queries, reporting to the FDA and ultimately improving clinical operations.”

Tweet this:  .@Comprehend expands #clinical data visualization and #analytics tool for sponsors, #CROs, #CTMS and #EDC vendors http://bit.ly/II63Cf

Now offering a fully validated solution, Comprehend Systems worked with BioPharm Systems to secure Title 21 CRF Part 11 compliance for Comprehend Clinical 1.1 and also put new standard operating procedures (SOPs) in place. In addition, the system’s new CDISC Study Data Tabulation Model (SDTM) adapter allows sponsors to connect Comprehend Clinical 1.1 to any SDTM data source and easily configure new SDTM studies.

“Comprehend Clinical 1.1 meets critical regulatory requirements that enable sponsors to submit fully validated electronic reports to the FDA, further streamlining the new drug submission and approval process,” said Alex Sefanov, CEO, BioPharm Systems. “With this new release, Comprehend further extended its commitment to the exchange of data using industry standards and meets a growing industry need for a solutions that enables sponsors to easily access and analyze data anytime and anywhere.”

Comprehend Clinical 1.1 also further improved its ability to connect researchers with key data with the following new features:

• Dashboard Embedding – Comprehend Clinical’s dashboards can now be embedded on any external website, web portal, SharePoint site and more. Based only in HTML and JavaScript, Comprehend dashboards also work on any mobile device, including the iPad and iPhone. Comprehend dashboards make it easy for users at any level of an organization, including data managers, CRAs, study managers and clinical operations executives to identify and adjust based on data trends. When a Comprehend dashboard raises a question that isn’t immediately answered within the dashboard, users can drill down (or “click through”) into any other pre-existing report or visualization.
• Expanded Chart Selection – Comprehend Clinical 1.1 now includes a range of new charts – including Pareto charts, candlestick plots, regression lines, pie charts and dashboard meters – that all enable full drill-downs into any other chart on the system and intelligently handle missing data. When certain points aren’t displayed on a graph because of missing or null data, Comprehend Clinical 1.1. is able to intelligently describe what was hidden, and allow the user to explore it further.

Comprehend Systems will be demonstrating its latest version of Comprehend Clinical at The DIA Annual Meeting in Philadelphia, June 24-28, at booth #2516.

About Comprehend Systems, Inc.

Comprehend Systems, Inc. (www.comprehend.com) offers clinical data visualization, analytics and reporting software that improves the way clinical researchers access, understand, explore and analyze data. Designed specifically for clinical researchers, Comprehend Clinical ™ enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Comprehend Systems was founded in 2010 in Palo Alto by a team of entrepreneurs with decades of combined experience in clinical research and software development.

Contact

Susan McCarron
617.986.5767
susan@comprehend.com

###

PALO ALTO, CALIF. – December 14, 2011 – Regulatory and financial pressures in clinical development have resulted in an increasing demand from sponsors and contract research organization (CROs) for user-friendly and comprehensive tools that offer the ability to easily access, explore and analyze clinical research data. While a number of analytics tools exist, most fail to meet the needs of drug and medical device developers looking to tackle a range of operational challenges. In response, Comprehend Systems has added new features and functionalities to its clinical data visualization and analytics software, Comprehend Clinical™, offering clinical developers unparalleled access to research data within individual trials and across multiple studies in a category or pipeline.

Tweet this: .@Comprehend expands #clinical development visualization and #analytics tool for sponsors, #CROs, and #EDC vendors http://bit.ly/rzxArW

Comprehend Clinical™ is a visualization and analytics tool created by industry veterans with a mission to help sponsors and CROs overcome key obstacles in clinical development. Unlike other visualization tools that are cumbersome and costly to implement, Comprehend Clinical™ is easy to deploy, use and integrate with other systems, including electronic data capture (EDC) and clinical trial management (CTMS). With simple, embeddable and interactive dashboards, Comprehend Clinical™ enables ad-hoc reporting from any data source in real-time. As a result, Comprehend Clinical™ offers a view into the most critical high-level operational metrics – from patient recruitment to serious adverse events – as well as the ability to drill down into specific issues that arise throughout the course of a trial – from protocol deviations to problematic sites.

“The application of analytics in clinical development isn’t new, but no one has really gotten it right – researchers are still looking for a tool that gives them access to the data they need and can be easily embedded into their existing workflow,” said Rick Morrison, CEO of Comprehend Systems. “By working with the key players in clinical trials, including EDC vendors, CROs and sponsors, Comprehend is poised to fill the market need for a simple, web-enabled data visualization and reporting tool that is customized for the clinical space.”

Using Comprehend Clinical™, CROs are able to provide their customers with better access to their data, and EDC vendors can supplement their offering with best-in-show analytics. New features in Comprehend Clinical™ include:

• Mobile access – Comprehend Clinical™ dashboards are now functional on web-enabled mobile devices, including smart phones and the iPad, and can be embedded on any web portal or SharePoint site.
• Drag-and-drop ad-hoc reporting – Users can easily and quickly create more complex visualizations and customized, real-time reports.
• Custom dashboards – Dashboards can be customized by the user to ensure they are getting up-to-date access to the data that is most important to them and drill down as necessary.

Comprehend Systems is working with BioPharm Systems to ensure that Comprehend Clinical™ is fully Title 21 CFR Part 11 compliant. The company also recently closed $1.2 million in seed round funding for ongoing development of Comprehend Clinical™.

About Comprehend Systems, Inc.

Comprehend Systems, Inc. (www.comprehend.com) offers clinical data visualization, analytics and reporting software that improves the way clinical researchers access, understand, explore and analyze data. Designed specifically for clinical researchers, Comprehend Clinical™ enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Comprehend Systems was founded in 2010 in Palo Alto by a team of entrepreneurs with decades of combined experience in clinical research and software development.

Contact

Susan McCarron
617.986.5767
susan@comprehend.com

PALO ALTO, CALIF. – November 8, 2011 – Driven by increasing demand from drug and medical device developers for cost-effective and user-friendly data analytics tools, Comprehend Systems, Inc. closed $1.2 million in seed round funding to support further development of Comprehend Clinical™, its clinical data visualization and analytics software. The round included contributions from Y Combinator, Start Fund, SV Angel, Yuri Milner, Menlo Ventures Talent Fund, Paul Buchheit, Garry Tan, Quotidian Ventures and Crosslink Capital, as well as a range of other angel investors with clinical research and enterprise sales expertise.

Tweet this: Comprehend (@Comprehend) raises $1.2MM for next stage growth, including @Ycombinator, SV Angel, Yuri Milner, and others http://bit.ly/w5d02y

“The application of business informatics and analytics is relatively new to clinical research, and the visualization and reporting tools available today are either cumbersome and costly to implement or not tailored to meet the needs of this industry, which comes with complex regulatory requirements,” said Rich Enz, investor and advisor. “Backed by decades of experience in clinical research, Comprehend is working to fill a critical market need for customized tools that easily work with existing systems and enable sponsors to be more effective and strategic with their clinical data.”

Comprehend Systems was founded in 2010 with a mission to improve the way clinical research sponsors access, understand, explore and analyze data. The company has already filed multiple patents for its technology. Its first software product, Comprehend Clinical™, easily integrates study data from any source – from electronic data capture (EDC), to safety, to clinical trial management systems (CTMS) – into one visualization and analytics platform. Designed specifically for clinical researchers, the tool enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Features include simple drag-and-drop ad-hoc reporting, elegant and powerful dashboards, and intelligent drilldown.

“The pharmaceutical industry has invested billions of dollars in technologies to collect and protect their clinical data – one of their most vital assets. But while tools like EDC and CTMS have matured, and CROs have become technology-savvy, sponsors still struggle to maximize the value of all that data in an easy, cost-effective way that enables them to make smarter, faster decisions about their clinical trials,” said Rick Morrison, CEO of Comprehend Systems. “As we move into our next stage of growth, we’re looking to continue to build momentum around our solution and work with sponsors and CROs to put data from across the clinical trial process at their fingertips.”

After beta-testing with pharmaceutical companies and academic research organizations, Comprehend will use this round of funding to introduce new features and functionality based on customer feedback. Comprehend also recently secured several advisory board members who will play a key role in driving corporate, product and sales strategy, including:

• Marc L. Abramowitz – Private investor with extensive experience in the health care services and device industry;
• Rich Enz – Over 35 years clinical systems software development experience;
• Alex Sefanov – Founder and CEO of life sciences IT consulting company BioPharm Systems;
• Kirill Sheynkman – Managing Director of RTP Ventures, three-time founder and CEO of software companies including Plumtree Software and Elastra; and
• Garry Tan – Co-founder of Posterous and venture partner at Y Combinator.

About Comprehend Systems, Inc.

Comprehend Systems, Inc. (www.comprehend.com) offers clinical data visualization, analytics and reporting software that improves the way clinical researchers access, understand, explore and analyze data. Designed specifically for clinical researchers, Comprehend Clinical™ enables data managers, monitors and clinical operations executives to identify broad operational and clinical trends across trials and also easily drill down and report on a wide range of factors, including safety issues, regulatory requirements and opportunities for critical time and cost savings. Comprehend Systems was founded in 2010 in Palo Alto by a team of entrepreneurs with decades of combined experience in clinical research and software development.

Contact

Susan McCarron
617.986.5767
susan@comprehend.com

We’ve put together a presentation that describes how a CRO could benefit from Comprehend Clinical. Below are some example slides, and if you’d like to download the full presentation, for free, just fill out the form below.